Persistent elevation of serum LBP, IL-23 and IL-6 in infliximab-maintained Crohn's disease: a case–control study from Iraq with the serum LBP/albumin ratio as a novel composite biomarker

Journal of Genetic Engineering and Biotechnology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles